---
title: "Palisade Bio (PALI.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PALI.US/norm.md"
symbol: "PALI.US"
name: "Palisade Bio"
parent: "https://longbridge.com/en/quote/PALI.US.md"
datetime: "2026-03-14T17:31:19.633Z"
locales:
  - [en](https://longbridge.com/en/quote/PALI.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PALI.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PALI.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/PALI.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/PALI.US/norm.md)


# Palisade Bio (PALI.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3837 | -0.5803 | -0.4650 | -1.55 | -2.32 |
| ROE | -393.69% | -280.26% | -139.17% | -189.78% | -168.53% |
| Revenue | - | - | - | - | - |
| Net income | -2.87M | -2.78M | -2.23M | -3.34M | -3.49M |
| Operating income | -2.92M | -2.84M | -2.31M | -3.38M | -3.59M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 6.97M | 6.67M | 8.19M | 10.88M | 9.34M |
| Leverage | 2.17 | 2.54 | 1.54 | 1.45 | 1.41 |
| BVPS | 0.3520 | 0.5454 | 1.21 | 2.71 | 5.51 |
| Turnover | - | - | - | - | 0.0000 |
| Cash & STI | 5.23M | 5.43M | 7.24M | 9.83M | 8.05M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | 23000.00 | 55000.00 | 87000.00 | 116000.00 |
| Net debt | -5.02M | -5.09M | -7.18M | -9.66M | -7.70M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -3.55M | -1.82M | -2.33M | -2.38M | -3.13M |
| Investing CF | - | - | - | - | - |
| Financing CF | 3.36M | 4000.00 | -258000.00 | 4.16M | -180000.00 |
| Free CF | -2.69M | -1.10M | -1.71M | -1.14M | -2.04M |
| OCF coverage | -3553.00% | - | -2916.25% | -1526.28% | -2797.32% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |